1964年Dotter 等首次应用经皮穿刺腔内血管成形术(PTA)治疗外围动脉粥样硬化性狭窄获得成功。十年后Grüntzig 发展了双腔气囊导管扩大了PTA 的临床应用范围。1971年PTA 应用于肾动脉狭窄的治疗,从此开僻了一条肾血管性高血压的非手术治疗的新方法,由于方法简便、疗效好等优点,目前已成为肾血管性高血压首选的治疗方法。经皮穿刺腔内肾血管成形术(PTRA)的临床应用:一、PTRA 的适应症:肾血管性高血压在美国发病率占高血压5%,可伴有严重 In 1964 Dotter and other first application of percutaneous transluminal angioplasty (PTA) in the treatment of peripheral atherosclerotic stenosis was successful. Ten years later Grüntzig developed a dual-lumen balloon catheter to expand the clinical application of PTA. 1971 PTA used in the treatment of renal artery stenosis, from which a new method of non-surgical treatment of renal vascular hypertension, due to the method is simple, good effect, etc., has now become the preferred treatment of renal vascular hypertension . Clinical application of percutaneous transluminal renal angioplasty (PTRA): First, the indications for PTRA: The incidence of renal vascular hypertension in the United States accounts for 5% of hypertension, may be associated with severe